Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bloor

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
AIDS (London, England)|January 12, 2001
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureV Miller, C Sabin, K Hertogs, et al.
AIDS (London, England)|June 10, 1998
The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitorsV Miller, M Stürmer, S Staszewski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Resistance to antiretroviral therapy among patients in UgandaP J Weidle, C M Kityo, P Mugyenyi, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistanceB A Larder, S Bloor, S D Kemp, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184VK Hertogs, S Bloor, V De Vroey, et al.
AIDS Research and Human Retroviruses|September 10, 1999
The rabbit study: ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patientsD R Churchill, A S Pym, S Galpin, et al.
AIDS (London, England)|April 24, 2001
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective studyW Verbiest, S Brown, C Cohen, et al.
AIDS (London, England)|June 15, 2000
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnelS A Wegner, S K Brodine, J R Mascola, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugsK Hertogs, M P de Béthune, V Miller, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
AIDS (London, England)|January 12, 2001
Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failureV Miller, C Sabin, K Hertogs, et al.
AIDS (London, England)|June 10, 1998
The M184V mutation in HIV-1 reverse transcriptase (RT) conferring lamivudine resistance does not result in broad cross-resistance to nucleoside analogue RT inhibitorsV Miller, M Stürmer, S Staszewski, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 8, 2001
Resistance to antiretroviral therapy among patients in UgandaP J Weidle, C M Kityo, P Mugyenyi, et al.
Antimicrobial Agents and Chemotherapy|August 3, 1999
A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistanceB A Larder, S Bloor, S D Kemp, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184VK Hertogs, S Bloor, V De Vroey, et al.
AIDS Research and Human Retroviruses|September 10, 1999
The rabbit study: ritonavir and saquinavir in combination in saquinavir-experienced and previously untreated patientsD R Churchill, A S Pym, S Galpin, et al.
AIDS (London, England)|April 24, 2001
Prevalence of HIV-1 drug resistance in antiretroviral-naive patients: a prospective studyW Verbiest, S Brown, C Cohen, et al.
AIDS (London, England)|June 15, 2000
Prevalence of genotypic and phenotypic resistance to anti-retroviral drugs in a cohort of therapy-naïve HIV-1 infected US military personnelS A Wegner, S K Brodine, J R Mascola, et al.
Antimicrobial Agents and Chemotherapy|April 4, 1998
A rapid method for simultaneous detection of phenotypic resistance to inhibitors of protease and reverse transcriptase in recombinant human immunodeficiency virus type 1 isolates from patients treated with antiretroviral drugsK Hertogs, M P de Béthune, V Miller, et al.
Pageof 3